Autolus Therapeutics PLC banner

Intrinsic Value

Is 6A3A undervalued or overvalued?

See the intrinsic value estimate for Autolus Therapeutics PLC and find out whether today’s valuation is cheap or expensive by its own historical standards.

Do our valuations actually work? See backtest results .

6A3A Intrinsic Value
LOCKED
Unlock
Today vs. history

6A3A looks undervalued.
But is it cheap by its own standards?

See how today’s valuation compares with 6A3A’s past valuations and how the stock performed after similar periods.

See what happened next Free account required
Monitor 6A3A
Get notified when the price drops
Track Buy Zone
20% below Intrinsic Value
Get notified when the price drops into your buy zone
Intrinsic Value Locked
Margin of Safety 20% Locked
Current Price €1.78
Or choose another margin of safety
0% below Intrinsic Value
10% below Intrinsic Value
30% below Intrinsic Value
40% below Intrinsic Value
50% below Intrinsic Value
Custom
Alternatives to 6A3A

Fundamental Analysis

What Autolus Therapeutics Does

Biotechnology Health Care

Autolus Therapeutics is a biotech company that develops engineered T-cell therapies, better known as CAR-T treatments, for certain blood cancers. Its medicines are made from a patient’s own immune cells, which are collected, modified in a lab to attack cancer, and then given back to the patient. The company’s work sits in the highly specialized cell-therapy part of drug development, where the main goal is to turn living cells into targeted cancer treatments.

Headquarters
United Kingdom UK
Employees
754
IPO date
Jun 22, 2018
Read the full company overview
View Company Overview
Financials
Efficiency

Earnings Waterfall
Autolus Therapeutics PLC

Wall St Price Targets

Capital Returns

Buyback Yield
LOCKED
Debt Paydown Yield
LOCKED

Competitive Landscape

Ownership

AUTL Insider Trading
Buy and sell transactions by insiders

What is the Intrinsic Value of one 6A3A stock?

The intrinsic value for Autolus Therapeutics PLC (6A3A) under the Base Case is hidden EUR.

Is 6A3A stock undervalued or overvalued?

Compared with the current market price of 1.78 EUR, the stock appears hidden.

Back to Top